Cours Acerus Pharmaceuticals Corporation Toronto S.E.
Actions
ASP
CA00444G4051
Produits pharmaceutiques
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17/07/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09/09/13 |
Borys Chabursky
BRD | Director/Board Member | - | 20/12/15 |
Varia. 1 janv. | Capi. | |
---|---|---|
+24,60 % | 654 Md | |
+24,08 % | 552 Md | |
-5,63 % | 356 Md | |
+15,37 % | 319 Md | |
+7,38 % | 295 Md | |
+3,26 % | 211 Md | |
+0,78 % | 206 Md | |
-9,69 % | 147 Md | |
-6,63 % | 144 Md |